These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
608 related articles for article (PubMed ID: 34372552)
1. The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications. Veluswamy P; Wacker M; Stavridis D; Reichel T; Schmidt H; Scherner M; Wippermann J; Michels G Viruses; 2021 Jul; 13(7):. PubMed ID: 34372552 [TBL] [Abstract][Full Text] [Related]
2. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects? Lui KO; Ma Z; Dimmeler S Cardiovasc Res; 2024 Feb; 120(1):34-43. PubMed ID: 38159046 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis. Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423 [TBL] [Abstract][Full Text] [Related]
6. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection. Maiuolo J; Mollace R; Gliozzi M; Musolino V; Carresi C; Paone S; Scicchitano M; Macrì R; Nucera S; Bosco F; Scarano F; Zito MC; Ruga S; Tavernese A; Mollace V Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291346 [TBL] [Abstract][Full Text] [Related]
7. Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury. Rossouw TM; Anderson R; Manga P; Feldman C Front Immunol; 2022; 13():776861. PubMed ID: 35185878 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2, ACE2 expression, and systemic organ invasion. Ashraf UM; Abokor AA; Edwards JM; Waigi EW; Royfman RS; Hasan SA; Smedlund KB; Hardy AMG; Chakravarti R; Koch LG Physiol Genomics; 2021 Feb; 53(2):51-60. PubMed ID: 33275540 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19. Kuba K; Yamaguchi T; Penninger JM Front Immunol; 2021; 12():732690. PubMed ID: 35003058 [TBL] [Abstract][Full Text] [Related]
13. Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones. Viveiros A; Rasmuson J; Vu J; Mulvagh SL; Yip CYY; Norris CM; Oudit GY Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H296-H304. PubMed ID: 33275517 [TBL] [Abstract][Full Text] [Related]
14. COVID-19, ACE2, and the cardiovascular consequences. South AM; Diz DI; Chappell MC Am J Physiol Heart Circ Physiol; 2020 May; 318(5):H1084-H1090. PubMed ID: 32228252 [TBL] [Abstract][Full Text] [Related]
15. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2). Xiang Y; Wang M; Chen H; Chen L Biochem Pharmacol; 2021 Oct; 192():114724. PubMed ID: 34371003 [TBL] [Abstract][Full Text] [Related]
16. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target. Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 Pandemic and Male Fertility: Clinical Manifestations and Pathogenic Mechanisms. Abdel-Moneim A Biochemistry (Mosc); 2021 Apr; 86(4):389-396. PubMed ID: 33941061 [TBL] [Abstract][Full Text] [Related]
18. Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review. Saba L; Gerosa C; Fanni D; Marongiu F; La Nasa G; Caocci G; Barcellona D; Balestrieri A; Coghe F; Orru G; Coni P; Piras M; Ledda F; Suri JS; Ronchi A; D'Andrea F; Cau R; Castagnola M; Faa G Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12609-12622. PubMed ID: 33336781 [TBL] [Abstract][Full Text] [Related]